Brief: Tetra Bio-Pharma Receives Favorable Response Following Type B Meeting With U.S. FDA For CAUMZ

Tetra Bio Pharma

01/02/2020 24:41

Jan 31 (Reuters) - Tetra Bio Pharma Inc  TBP.V :
    * RECEIVED A FAVORABLE LETTER FROM UNITED STATES FOOD AND
DRUG
ADMINISTRATION WITH RESPECT TO CAUMZ

Source text for Eikon:  ID:nCNWmHvD1a 
Further company coverage:  TBP.V 

 ((Reuters.Briefs@thomsonreuters.com;))